Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model-Reference-Cited by-同舟云学术

Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model

Published:2018-09-11 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Belloni Laura,Di Cocco Silvia,Guerrieri Francesca,Nunn Abigail D. G.,Piconese Silvia,Salerno Debora,Testoni Barbara,Pulito Claudio,Mori Federica,Pallocca Matteo,Sacconi Andrea,Vivoli Elisa,Marra Fabio,Strano Sabrina,Blandino Giovanni,Levrero Massimo,Pediconi Natalia

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-31835-2.pdf

Reference39 articles.

1. Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 15(1), 11–20 (2018).

2. Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. & Tiribelli, C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends in Molecular Medicine. 14, 72–81 (2008).

3. Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 51(5), 1820–1832 (2010).

4. Anstee, Q. M. & Day, C. P. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 10(11), 645–55 (2013).

5. He, G. & Karin, M. NF-kappaB and STAT3 – key players in liver inflammation and cancer. Cell Res. 21, 159–168 (2011).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease Progression;Biology Bulletin;2024-09-10

2. Exploring the mechanism of dendrobine in treating metabolic associated fatty liver disease based on network pharmacology and experimental validation;Hereditas;2024-05-16

3. Exploring the Mechanism of Dendrobine in Treating Non-Alcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Validation;2024-01-08

4. Rice Bran Extract Suppresses High-Fat Diet-Induced Hyperlipidemia and Hepatosteatosis through Targeting AMPK and STAT3 Signaling;Nutrients;2023-08-18

5. Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways;Heliyon;2023-03